Emerging Microbes & Infections

(The H4-Index of Emerging Microbes & Infections is 70. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-10-01 to 2023-10-01.)
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan2097
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes1282
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody976
Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients869
Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors746
Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia578
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2575
Laboratory diagnosis of emerging human coronavirus infections – the state of the art538
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension468
Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26452
RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak401
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists379
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients368
Identification of novel mobile colistin resistance gene mcr-10311
Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity308
Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)282
A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses275
ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens264
COVID-19 pandemic – an African perspective261
The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron259
Clinical observation and management of COVID-19 patients259
SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells258
Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost254
Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient248
Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction247
Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2238
The different clinical characteristics of corona virus disease cases between children and their families in China – the character of children with COVID-19231
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies231
A serological survey of SARS-CoV-2 in cat in Wuhan218
Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients208
Rapid inactivation of SARS-CoV-2 with deep-UV LED irradiation203
Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells192
SARS-CoV-2 infection, disease and transmission in domestic cats184
Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case–control real-world study183
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic170
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection163
Patterns of IgG and IgM antibody response in COVID-19 patients160
Experimental aerosol survival of SARS-CoV-2 in artificial saliva and tissue culture media at medium and high humidity139
SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species138
Antibody titres decline 3-month post-vaccination with BNT162b2134
Short- and potential long-term adverse health outcomes of COVID-19: a rapid review126
Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine119
Risks and features of secondary infections in severe and critical ill COVID-19 patients117
The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor116
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection113
Antibodies in the breast milk of a maternal woman with COVID-19112
High neutralizing antibody titer in intensive care unit patients with COVID-19112
SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East108
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates107
Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells106
Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)104
Emergence and spread of novel H5N8, H5N5 and H5N1 clade highly pathogenic avian influenza in 2020104
Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)104
Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets98
Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-296
Susceptibility of rabbits to SARS-CoV-294
Genotype I African swine fever viruses emerged in domestic pigs in China and caused chronic infection94
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease92
Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture89
Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies85
Risk factors associated with COVID-19 infection: a retrospective cohort study based on contacts tracing85
Next-generation pathogen diagnosis with CRISPR/Cas-based detection methods82
Serological differentiation between COVID-19 and SARS infections81
Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae81
Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters80
Lack of cross-neutralization by SARS patient sera towards SARS-CoV-279
Diagnostic value and key features of computed tomography in Coronavirus Disease 201977
The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan76
Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity72
Susceptibility of swine cells and domestic pigs to SARS-CoV-272
The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections70